ONCT logo

Oncternal Therapeutics (ONCT) Company Overview

Profile

Full Name:

Oncternal Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 3, 2004

Indexes:

Not included

Description:

Oncternal Therapeutics is a biotechnology company focused on developing innovative cancer therapies. They specialize in targeted treatments for various cancers, aiming to improve patient outcomes through advanced research and clinical trials. Their pipeline includes therapies that address unmet medical needs in oncology.

Events Calendar

Earnings

Next earnings date:

Mar 7, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 8, 2024

Analyst ratings

Recent major analysts updates

Aug 12, 24 HC Wainwright & Co.
Buy
Jul 16, 24 HC Wainwright & Co.
Buy
May 31, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Apr 15, 24 HC Wainwright & Co.
Buy
Jan 29, 24 HC Wainwright & Co.
Buy
Dec 27, 23 HC Wainwright & Co.
Buy
Dec 4, 23 Brookline Capital
Buy
Sep 18, 23 HC Wainwright & Co.
Buy
Sep 7, 23 Cantor Fitzgerald
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Oncternal Therapeutics?
  • Does Oncternal Therapeutics pay dividends?
  • What sector is Oncternal Therapeutics in?
  • What industry is Oncternal Therapeutics in?
  • What country is Oncternal Therapeutics based in?
  • When did Oncternal Therapeutics go public?
  • Is Oncternal Therapeutics in the S&P 500?
  • Is Oncternal Therapeutics in the NASDAQ 100?
  • Is Oncternal Therapeutics in the Dow Jones?
  • When was Oncternal Therapeutics's last earnings report?
  • When does Oncternal Therapeutics report earnings?
  • Should I buy Oncternal Therapeutics stock now?

What is the ticker symbol for Oncternal Therapeutics?

The ticker symbol for Oncternal Therapeutics is NASDAQ:ONCT

Does Oncternal Therapeutics pay dividends?

No, Oncternal Therapeutics does not pay dividends

What sector is Oncternal Therapeutics in?

Oncternal Therapeutics is in the Healthcare sector

What industry is Oncternal Therapeutics in?

Oncternal Therapeutics is in the Biotechnology industry

What country is Oncternal Therapeutics based in?

Oncternal Therapeutics is headquartered in United States

When did Oncternal Therapeutics go public?

Oncternal Therapeutics's initial public offering (IPO) was on February 3, 2004

Is Oncternal Therapeutics in the S&P 500?

No, Oncternal Therapeutics is not included in the S&P 500 index

Is Oncternal Therapeutics in the NASDAQ 100?

No, Oncternal Therapeutics is not included in the NASDAQ 100 index

Is Oncternal Therapeutics in the Dow Jones?

No, Oncternal Therapeutics is not included in the Dow Jones index

When was Oncternal Therapeutics's last earnings report?

Oncternal Therapeutics's most recent earnings report was on Nov 6, 2024

When does Oncternal Therapeutics report earnings?

The next expected earnings date for Oncternal Therapeutics is Mar 7, 2025

Should I buy Oncternal Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions